The problem with treating Alzheimer’s is that once the symptoms start showing up, it’s already too late—meaning that early detection is absolutely vital in coming up with working solutions. Using the power of machine learning, IBM researchers have figured out a way to detect a biological marker associated with the disease through a simple blood test. Apparently, that biological marker, which is found in spinal fluid, starts changing decades before the first signs of the disease show up. The problem is harvesting spinal fluid for testing is highly invasive and expensive, making it not ideal for an early detection procedure. What the IBM scientists have figured out is that it’s possible to identify the proteins in the blood that can predict the concentration of the biomarker in spinal fluid, making early detection not only possible but also affordable. The method is still in its early stages of testing, but in the future, scientists could use it to find appropriate subjects for programs developing a cure.
IBM is using machine learning to detect Alzheimer’s way before symptoms show up
More of Today's Solutions
This bike for two lets you pedal through the forest on old train tracks
In an effort to breathe new life into some of America’s historic railway lines, Skunk Train is repurposing unused train tracks as adventurous tour ...
Read MoreClosing the longevity gap: what research reveals about why women live longer
BY THE OPTIMIST DAILY EDITORIAL TEAM Across the animal kingdom, females tend to live longer than males, and the same is true for humans. ...
Read MoreCanada sets new methane rules to curb oil and gas emissions by 75 percent by ...
BY THE OPTIMIST DAILY EDITORIAL TEAM In a long-anticipated move, Canada has introduced tougher methane regulations for its oil and gas sector, an industry ...
Read MoreWhy turning support into action matters on International Women’s Day
BY THE OPTIMIST DAILY EDITORIAL TEAM International Women’s Day arrives each year with a familiar mix of brightness and gravity. On March 8, communities ...
Read More
